Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction
K. Takenaka, S. Yasuda, S. Miyazaki, T. Kurita, Y. Sutani, I. Morii, S. Daikoku, S. Kamakura, H. Nonogi
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction'. Together they form a unique fingerprint.